ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

0.0001
0.00
( 0.00% )
Updated: 18:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000058 52 Week Range 0.0003
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ARNI Latest News

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
26-0.0002-66.66666666670.00030.00030.000174920.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-665097.433E-5CS
260-0.0016-94.11764705880.00170.0421.0E-6644990.00498007CS

ARNI - Frequently Asked Questions (FAQ)

What is the current Arno Therapeutics (CE) share price?
The current share price of Arno Therapeutics (CE) is US$ 0.0001
What is the 1 year trading range for Arno Therapeutics (CE) share price?
Arno Therapeutics (CE) has traded in the range of US$ 0.000058 to US$ 0.0003 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.20
(199,900.00%)
100
EESOEnzyme Environmental Solutions Inc (CE)
US$ 0.0001
(9,900.00%)
3.97M
ALKMAlkame Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
100k
PSRUValiant Eagle Inc (PK)
US$ 0.0001
(9,900.00%)
15.37M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(9,900.00%)
327.12M
TTMZFDatable Technology Corporation (CE)
US$ 0.000001
(-100.00%)
1,000
PKLBFPerk Labs Inc (CE)
US$ 0.000001
(-99.67%)
9k
CLVRClever Leaves Holdings Inc (CE)
US$ 0.0001
(-99.60%)
1.6k
QBIOQ BioMed Inc (CE)
US$ 0.000001
(-99.50%)
100
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0.000001
(-99.50%)
110
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(9,900.00%)
327.12M
PHILPHI Group Inc (PK)
US$ 0.0002
(0.00%)
184.35M
TKMOTekumo Inc (PK)
US$ 0.0003
(-14.29%)
182.33M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(50.00%)
164.2M
ASIIAccredited Solutions Inc (PK)
US$ 0.00045
(0.00%)
134.76M

Discussion

View Full Feed
Lime Time Lime Time 3 minutes ago
Peeps gotta get off the 0006s and let it cruise
EEGI
Penny Stocks 2.0 Penny Stocks 2.0 3 minutes ago
$HADV .0012 going Explosion coming...
HADV
primecomm primecomm 4 minutes ago
Volume precedes Price $$$$
GRLF
urge2surge urge2surge 4 minutes ago
Somebody possibly sold today. You?
They're on top of a lot and the market isn't giving them the proper treatment. Mm games as I've witnessed since the initial spike. Subsequently this is the reason why their uplisting. Announcement at anytime.
Whoever sold, I hope they aren't able to r
FDCT
The Night Stalker The Night Stalker 4 minutes ago
will see new lows then RS
BNZI
Penny Stocks 2.0 Penny Stocks 2.0 4 minutes ago
$HADV .0012 going Explosion coming...
HADV
Carjockey2 Carjockey2 4 minutes ago
See what I mean about HMBL dirtballs..

Disgusting and I should listen or care..

Pass

$HMBL
HMBL
gitreal gitreal 4 minutes ago
can you Admit it's a Gold/Silver Processing Facility with AABB Behind it's Construction!

No and no.
AABB
dexprs dexprs 4 minutes ago
Sold APP at 380 and OKTA for nice gains.
DECK and JPM may have to wait another day. As well as SON and BILL.
JPM
Triple nickle Triple nickle 4 minutes ago
SES added 10k at 1.20 
SES
DruidOracle55 DruidOracle55 4 minutes ago
Doesn't matter anymore
AXXA
PENNY PIRATE PENNY PIRATE 5 minutes ago
JonDoe1 ... IMHO, Benny is an Enthusiastic Investor! The OTC is Notoriously Risky, but that said, AABB has Nothing to do with any Other OTC besides KYNC which appears to have had a hand in the Development of the New Wallet! Why would anyone who is Not Invested in AABB be here? Either they are Watchi
AABB KYNC
rickstereo3333 rickstereo3333 5 minutes ago
Apparently the Muppet sceeate believes that a trial's initial dosage is always 100% effective on the first attempt.

Not to mention, once again, that the site chosen ie lymph nodes, had limited to no other treatment option available thus making the 80% reduction in one patient even mor
RDGL
tapioca tapioca 5 minutes ago
What are you a comedian? That is very funny ..
GRLF
dinogreeves dinogreeves 5 minutes ago
Would it make sense to dilute here to pay for the project to the tune of 8 billion dollars? Or would it make sense to reverse merge and do a reverse split ratio of 1 for 10, assuming the price is between 4-5 dollars after the merger and list on major exchange for $40-$50 dollars and do a secondary
TGLO
Lone Clone Lone Clone 5 minutes ago
First Majestic Reports Exploration Success for Navidad at Santa Elena

New drilling significantly expands the high-grade gold and silver mineralization of the Navidad discovery.
Metallurgical testing demonstrates excellent gold and silver recoveries for Navidad mineralization
Mark Mark 5 minutes ago
$LNKS added a few, bottomed out.
LNKS
CatfishHunter CatfishHunter 5 minutes ago
Always easy to ignore a question you're afraid to answer.  
RDGL
RIGATONI RIGATONI 5 minutes ago
wow, take a look at this 8K from...

ETST .1789

https://x.com/rigatoni33/status/1886859305728794971
ETST
dennisdave dennisdave 5 minutes ago
Itrs going to be Mid March-End March
NWBO
Mr. Dragon Mr. Dragon 5 minutes ago
Does anyone know where Fraudman is? Did he already run off to Vietnam or is he hiding in his CA home with the bars on the windows?
PHIL
otterman otterman 5 minutes ago
And your certifications are? You know, since youre giving out financial advice.
DBMM
Poo28 Poo28 6 minutes ago
This crazy fable must be over 1,000 words and howling at the moon will take an hour !

“2025 will be the best year ever for DBMM! “

Bashers terrified of losing their gig as DBMM will be flying . They will get caught up in whirlwind !

https://www.dbmmgroup.
DBMM